Deep-intronic variants in CNGB3 cause achromatopsia by pseudoexon activation.


Journal

Human mutation
ISSN: 1098-1004
Titre abrégé: Hum Mutat
Pays: United States
ID NLM: 9215429

Informations de publication

Date de publication:
01 2020
Historique:
received: 20 05 2019
revised: 20 08 2019
accepted: 16 09 2019
pubmed: 24 9 2019
medline: 20 5 2021
entrez: 24 9 2019
Statut: ppublish

Résumé

Our comprehensive cohort of 1100 unrelated achromatopsia (ACHM) patients comprises a considerable number of cases (~5%) harboring only a single pathogenic variant in the major ACHM gene CNGB3. We sequenced the entire CNGB3 locus in 33 of these patients to find a second variant which eventually explained the patients' phenotype. Forty-seven intronic CNGB3 variants were identified in 28 subjects after a filtering step based on frequency and the exclusion of variants found in cis with pathogenic alleles. In a second step, in silico prediction tools were used to filter out those variants with little odds of being deleterious. This left three variants that were analyzed using heterologous splicing assays. Variant c.1663-1205G>A, found in 14 subjects, and variant c.1663-2137C>T, found in two subjects, were indeed shown to exert a splicing defect by causing pseudoexon insertion into the transcript. Subsequent screening of further unsolved CNGB3 subjects identified four additional cases harboring the c.1663-1205G>A variant which makes it the eighth most frequent CNGB3 variant in our cohort. Compound heterozygosity could be validated in ten cases. Our study demonstrates that whole gene sequencing can be a powerful approach to identify the second pathogenic allele in patients apparently harboring only one disease-causing variant.

Identifiants

pubmed: 31544997
doi: 10.1002/humu.23920
pmc: PMC8182131
mid: NIHMS1693469
doi:

Substances chimiques

CNGB3 protein, human 0
Cyclic Nucleotide-Gated Cation Channels 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

255-264

Subventions

Organisme : Intramural NIH HHS
ID : ZIA EY000564
Pays : United States

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

Hum Mutat. 2015 Jan;36(1):43-7
pubmed: 25363634
Cold Spring Harb Perspect Med. 2014 Oct 16;5(2):a017111
pubmed: 25324231
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W71-4
pubmed: 17485472
Genet Med. 2015 Apr;17(4):262-70
pubmed: 25474345
Am J Hum Genet. 2006 Sep;79(3):556-61
pubmed: 16909394
Nucleic Acids Res. 2006;34(16):4630-41
pubmed: 16963498
Mol Ther Nucleic Acids. 2018 Sep 7;12:730-740
pubmed: 30114557
Bioinformatics. 2014 Sep 1;30(17):2503-5
pubmed: 24812344
Nucleic Acids Res. 2007;35(13):4250-63
pubmed: 17576681
Bioinformatics. 2016 Oct 1;32(19):3047-8
pubmed: 27312411
Mol Vis. 2012;18:751-7
pubmed: 22509105
Hum Genet. 2010 Feb;127(2):135-54
pubmed: 19823873
Hum Mol Genet. 2013 Dec 20;22(25):5136-45
pubmed: 23918662
Hum Mol Genet. 2014 Dec 20;23(25):6797-806
pubmed: 25082829
Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):394-403
pubmed: 28118664
Mol Reprod Dev. 2015 Jul-Aug;82(7-8):518-29
pubmed: 26153368
BMC Bioinformatics. 2016 May 10;17:208
pubmed: 27161244
Genet Med. 2018 Feb;20(2):202-213
pubmed: 28749477
Hum Mutat. 2016 Feb;37(2):184-93
pubmed: 26629787
Genome Biol. 2016 Jun 06;17(1):122
pubmed: 27268795
Hum Mutat. 2017 Nov;38(11):1579-1591
pubmed: 28795510
Bioinformatics. 2019 Sep 1;35(17):2966-2973
pubmed: 30649250
Nucleic Acids Res. 2009 May;37(9):e67
pubmed: 19339519
Hum Genet. 2017 Sep;136(9):1093-1111
pubmed: 28497172
Genet Med. 2019 Aug;21(8):1751-1760
pubmed: 30643219
Hum Mutat. 2012 Jan;33(1):104-8
pubmed: 22009552
Genet Med. 2019 Aug;21(8):1761-1771
pubmed: 30670881
Nucleic Acids Res. 2014 Jan;42(Database issue):D980-5
pubmed: 24234437
Science. 2003 May 23;300(5623):1288-91
pubmed: 12764196
In Silico Biol. 2004;4(4):387-93
pubmed: 15217358

Auteurs

Nicole Weisschuh (N)

Institute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.

Marc Sturm (M)

Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.

Britta Baumann (B)

Institute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.

Isabelle Audo (I)

Institut de la Vision, Sorbonne Université, INSERM, CNRS, Paris, France.
CHNO des Quinze-Vingts, INSERM-DHOS CIC1423, Paris, France.
Institute of Ophthalmology, University College of London, London, United Kingdom.

Carmen Ayuso (C)

Department of Genetics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital-Universidad Autónoma de Madrid (IIS-FJD UAM), Madrid, Spain.
Center for Biomedical Network Research on Rare Diseases (CIBERER), ISCIII, Madrid, Spain.

Beatrice Bocquet (B)

Centre National de Référence «Maladies Sensorielles Génétiques», Service Ophtalmologie, Hôpital Gui de Chauliac, CHRU de Montpellier, Montpellier, France.
INSERM U1051, Institute for Neurosciences of Montpellier, Montpellier, France.

Kari Branham (K)

Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan.

Brian P Brooks (BP)

National Eye Institute, National Institutes of Health, Bethesda, Maryland.

Jaume Catalá-Mora (J)

Ophthalmology, Hospital Sant Joan de Deu, Barcelona, Spain.

Roberto Giorda (R)

Molecular Biology Lab, Scientific Institute, IRCCS Eugenio Medea, Bosisio Parini, Italy.

John R Heckenlively (JR)

Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan.

Robert B Hufnagel (RB)

National Eye Institute, National Institutes of Health, Bethesda, Maryland.

Samuel G Jacobson (SG)

Department of Ophthalmology, Perelman School of Medicine, Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania.

Ulrich Kellner (U)

Rare Retinal Disease Center, Augenzentrum Siegburg, MVZ ADTC Siegburg GmbH, Siegburg, Germany.

Sofia Kitsiou-Tzeli (S)

Department of Medical Genetics, National & Kapodistrian University of Athens, Athens, Greece.

Alexandre Matet (A)

Department of Ophthalmology, Jules-Gonin Eye Hospital, University of Lausanne, Lausanne, Switzerland.

Loreto Martorell Sampol (L)

Laboratorio de Genética Molecular, Hospital Sant Joan de Deu, Barcelona, Spain.

Isabelle Meunier (I)

Center for Biomedical Network Research on Rare Diseases (CIBERER), ISCIII, Madrid, Spain.
Centre National de Référence «Maladies Sensorielles Génétiques», Service Ophtalmologie, Hôpital Gui de Chauliac, CHRU de Montpellier, Montpellier, France.

Günther Rudolph (G)

Department of Ophthalmology, Ludwig-Maximilians-University, Munich, Germany.

Dror Sharon (D)

Department of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Katarina Stingl (K)

University Eye Hospital, Center for Ophthalmology, University of Tübingen, Tübingen, Germany.

Berthold Streubel (B)

Department of Pathology, Medical University of Vienna, Vienna, Austria.

Balázs Varsányi (B)

Department of Ophthalmology, Semmelweis University, Budapest, Hungary.
Department of Ophthalmology, University of Pécs Medical School, Pécs, Hungary.

Bernd Wissinger (B)

Institute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.

Susanne Kohl (S)

Institute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH